NEW YORK (GenomeWeb) – Roche said today that it has received the CE IVD mark for its Cobas HPV assay on the Cobas 6800/8800 systems for cervical cancer screening.

Cobas HPV is a real-time PCR test that provides specific genotyping information for human papillomavirus 16 and 18, the highest-risk types, while simultaneously reporting the 12 other high-risk HPV types as a pooled result.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.